Shailesh Jain, MD

Letter to the Editor

Pimavanserin: A 2019 Clarification on the FDA Update

December 26, 2019

The authors of this letter to the editor comment on a previously published report on pimavanserin in The Primary Care Companion for CNS Disorders.

Original Research

Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data

September 17, 2007

Article

A Pilot Study of an Electronic, Adolescent Version of the Quick Inventory of Depressive Symptomatology

September 17, 2007